NASDAQ:CRDF

Cardiff Oncology Stock Predictions

etoro logo Buy CRDF
*Your capital is at risk
$1.40
-0.110 (-7.28%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

CRDF Prediction Chart

CRDF Predictions History

Latest community submissions for CRDF.
Predictor Target Session Target Price Result Direction Accuracy Score
Mar 25, 2024 $5.61 -4.12% $5.91 X 94.90% 0
Mar 25, 2024 $5.70 -2.58% $5.91 X 96.43% 0
Mar 25, 2024 Bullish $5.91 V 1
Mar 14, 2024 $5.22 -3.42% $5.40 X 96.58% 0
Mar 14, 2024 $5.28 -2.13% $5.40 X 97.87% 0
Mar 14, 2024 Bullish $5.40 V 0
Mar 12, 2024 $3.89 -3.72% $4.48 X 86.82% 0
Mar 12, 2024 $3.95 -2.32% $4.48 X 88.08% 0
Mar 12, 2024 Bullish $4.48 V 1
Skagitqg Skagitqg Merchant
Mar 12, 2024 Bullish $4.48 V 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CRDF with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CARDIFF ONCOLOGY INC.
Cardiff Oncology
Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; metastatic colorectal cancer that is in clinical trials; and TROV-054 is a Phase 1b/2 for FOLFIRI and bevac...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE